Li, Q., Shan, W., & Wu, S. Safety assessment of rosuvastatin-fenofibrate combination in the treatment of hyperlipidemia based on FDA’s adverse event reporting system database. Frontiers Media S.A.
Chicago Style (17th ed.) CitationLi, Qun, Wenya Shan, and Saiwei Wu. Safety Assessment of Rosuvastatin-fenofibrate Combination in the Treatment of Hyperlipidemia Based on FDA’s Adverse Event Reporting System Database. Frontiers Media S.A.
MLA (9th ed.) CitationLi, Qun, et al. Safety Assessment of Rosuvastatin-fenofibrate Combination in the Treatment of Hyperlipidemia Based on FDA’s Adverse Event Reporting System Database. Frontiers Media S.A.
Warning: These citations may not always be 100% accurate.